29 related articles for article (PubMed ID: 1717269)
1. Variability of human Alpha-1-acid glycoprotein N-glycome in a Caucasian population.
Vučković F; Novokmet M; Šoić D; Štambuk J; Kolčić I; Polašek O; Lauc G; Gornik O; Keser T
Glycobiology; 2024 Apr; 34(6):. PubMed ID: 38591797
[TBL] [Abstract][Full Text] [Related]
2. Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: relationship to the absence of alpha3-fucosyltransferase in the liver.
Havenaar EC; Hoff RC; van den Eijnden DH; van Dijk W
Glycoconj J; 1998 Apr; 15(4):389-95. PubMed ID: 9613826
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.
van Dijk W; Havenaar EC; Brinkman-van der Linden EC
Glycoconj J; 1995 Jun; 12(3):227-33. PubMed ID: 7496136
[TBL] [Abstract][Full Text] [Related]
4. Microheterogeneity of alpha 1-acid glycoprotein in early and established rheumatoid arthritis.
Hrycaj P; Sobieska M; Mackiewicz S; Müller W
J Rheumatol; 1993 Dec; 20(12):2020-4. PubMed ID: 8014928
[TBL] [Abstract][Full Text] [Related]
5. Inducible and tissue-specific expression of rat alpha-1-acid glycoprotein in transgenic mice.
Dewey MJ; Rheaume C; Berger FG; Baumann H
J Immunol; 1990 Jun; 144(11):4392-8. PubMed ID: 2341724
[TBL] [Abstract][Full Text] [Related]
6. Acute phase mediated change in glycosylation of rat alpha 1-acid glycoprotein in transgenic mice.
Mackiewicz A; Dewey MJ; Berger FG; Baumann H
Glycobiology; 1991 Jun; 1(3):265-9. PubMed ID: 1794039
[TBL] [Abstract][Full Text] [Related]
7. The heterogeneity of the glycosylation of alpha-1-acid glycoprotein between the sera and synovial fluid in rheumatoid arthritis.
Smith KD; Pollacchi A; Field M; Watson J
Biomed Chromatogr; 2002 Jun; 16(4):261-6. PubMed ID: 11933026
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.
De Graaf TW; Van der Stelt ME; Anbergen MG; van Dijk W
J Exp Med; 1993 Mar; 177(3):657-66. PubMed ID: 7679706
[TBL] [Abstract][Full Text] [Related]
9. Effect of transgenic expression of human alpha 1-acid glycoprotein (AGP) on the glycosylation of human and mouse AGP in various transgenic mouse sera.
van Dijk W; van der Stelt ME; Salera A; Dente L
Eur J Cell Biol; 1991 Jun; 55(1):143-8. PubMed ID: 1717269
[TBL] [Abstract][Full Text] [Related]
10. Glycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer.
Mackiewicz A; Mackiewicz K
Glycoconj J; 1995 Jun; 12(3):241-7. PubMed ID: 7496138
[TBL] [Abstract][Full Text] [Related]
11. Appropriate mammalian expression systems for biopharmaceuticals.
Werner RG; Noé W; Kopp K; Schlüter M
Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
[TBL] [Abstract][Full Text] [Related]
12. The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases.
Ceciliani F; Pocacqua V
Curr Protein Pept Sci; 2007 Feb; 8(1):91-108. PubMed ID: 17305563
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
